Literature DB >> 7925683

Comparative toxicity of tetracaine, proparacaine and cocaine evaluated with primary cultures of rabbit corneal epithelial cells.

R L Grant1, D Acosta.   

Abstract

Cocaine was first used as a topical anesthetic for the eye by Dr Carl Koller in 1884. It became evident that this agent produced erosion of the corneal epithelium in high doses or with repeated use. Synthetic local anesthetics such as tetracaine and proparacaine were developed which were more potent and less toxic than cocaine, but still produced corneal epithelium defects if used chronically. This investigation was undertaken to compare and rank the cytotoxicity of the most commonly used ocular local anesthetics, tetracaine, proparacaine and cocaine, with primary cultures of rabbit corneal epithelial cells. Cultures were exposed to either low concentrations of local anesthetics for 4-24 hr or to higher concentrations of local anesthetics for 15-120 min. Plasma membrane integrity was evaluated by measuring leakage of the cytosolic enzyme, lactate dehydrogenase, into the medium. Cell shape changes were evaluated by observing morphological changes. Mitochondrial dehydrogenase activity and cell viability were assessed by measuring 3-(4,5-dimethythiazol-2yl)-2,5-diphenyl tetrazolium bromide reduction. The cytotoxicity of the local anesthetics as evaluated by the lactate dehydrogenase leakage cytotoxicity test was ranked as follows: tetracaine (EC50 = 0.96 mM) >> proparacaine (EC50 = 4.4 mM) > cocaine (EC50 = 9.7 mM). The mitochondrial reduction assay seemed to be more sensitive than the lactate dehydrogenase leakage test in predicting toxicity: tetracaine (EC50 = 0.81 mM) >> proparacaine (EC50 = 3.4 mM) > cocaine (EC50 = 7.1 mM). When corneal epithelial cells were treated with local anesthetics, marked morphological changes occurred at concentrations that did not cause a decrease in viability. This was especially true for cocaine-treated cells. Tetracaine and proparacaine have the same anesthetic potency in vivo, although tetracaine is considered to be more irritating than proparacaine. This in vitro study showed that tetracaine was approximately four times more toxic than proparacaine. Cocaine was less toxic in vitro than proparacaine and tetracaine when compared on an equimolar basis, but in vivo it may be more toxic because of the higher concentrations that must be used to obtain the same degree of anesthesia as well as its marked effects on cell morphology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925683     DOI: 10.1006/exer.1994.1040

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  11 in total

1.  Cytotoxic effect and possible mechanisms of Tetracaine on human corneal epithelial cells in vitro.

Authors:  Xin Pang; Ting-Jun Fan
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

2.  Long-acting liposomal corneal anesthetics.

Authors:  Changyou Zhan; Claudia M Santamaria; Weiping Wang; J Brian McAlvin; Daniel S Kohane
Journal:  Biomaterials       Date:  2018-08-09       Impact factor: 12.479

3.  Tetracaine 0.5% eyedrops with or without lidocaine 2% gel in topical anesthesia for cataract surgery.

Authors:  Anthoula T Tsoumani; Ioannis C Asproudis; Dimitrios Damigos
Journal:  Clin Ophthalmol       Date:  2010-09-07

4.  A digitized fluorescence imaging study of intracellular Ca2+, pH, and mitochondrial function in primary cultures of rabbit corneal epithelial cells exposed to sodium dodecyl sulfate.

Authors:  W Yang; D Acosta
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995 Jul-Aug       Impact factor: 2.416

5.  Synthetic neurotensin analogues are nontoxic analgesics for the rabbit cornea.

Authors:  Charles Kim; Denise Barbut; Murk H Heinemann; Gavril Pasternak; Mark I Rosenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-13       Impact factor: 4.799

6.  Toxic keratopathy associated with abuse of topical anesthetics and amniotic membrane transplantation for treatment.

Authors:  Ozlem Yalcin Tok; Levent Tok; Inci Meltem Atay; Tugba Cakmak Argun; Nazire Demirci; Alime Gunes
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

7.  Prolonged Duration Topical Corneal Anesthesia With the Cationic Lidocaine Derivative QX-314.

Authors:  Alan G Woodruff; Claudia M Santamaria; Manisha Mehta; Grant L Pemberton; Kathleen Cullion; Daniel S Kohane
Journal:  Transl Vis Sci Technol       Date:  2019-10-17       Impact factor: 3.283

8.  Prospective, randomized, contralateral eye comparison of tetracaine and proparacaine for pain control in laser in situ keratomileusis and photorefractive keratectomy.

Authors:  Majid Moshirfar; Mark D Mifflin; Michael V McCaughey; Adam J Gess
Journal:  Clin Ophthalmol       Date:  2014-06-26

9.  Evaluation of the anesthetic effect of nasal mucosa with tetracaine 0.5% on hemodynamic changes and postoperative pain of septoplasty: A randomized controlled trial.

Authors:  Hossein Madineh; Soroush Amani; Majid Kabiri; Behnam Karimi
Journal:  J Adv Pharm Technol Res       Date:  2017 Oct-Dec

10.  Effects of topical flurbiprofen sodium, diclofenac sodium, ketorolac tromethamine and benzalkonium chloride on corneal sensitivity in normal dogs.

Authors:  Raquel de Araújo Cantarella; Juliana Kravetz de Oliveira; Daniel M Dorbandt; Fabiano Montiani-Ferreira
Journal:  Open Vet J       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.